Michael Neely

Translational Development of New Agents Alone and in Combination to Combat Gram-Negative Pathogens Important in Ventilator- Associated Bacterial Pneumonia: Leveraging the Gram-Negative Toolbox That Is

National Institute of Allergy and Infectious Diseases · P01

Project lead · $781.1K · University of Florida

Optimizing Multi-Drug Mycobacterium Tuberculosis Therapy for Rapid Sterilization and Resistance Suppression

National Institute of Allergy and Infectious Diseases · R01

PI · $2.7M · University of Florida

Precision Dosing for Critically Ill Children

National Institute of Child Health and Human Development · R01

Contact PI · $2.9M · Children's Hospital of Los Angeles

Sequestration and Deactivation of Anthracycline by Adipocytes in the Leukemia Microenvironment

National Cancer Institute · R01

PI · $1.9M · University of California Los Angeles

Development of Voriconazole Pharmacokinetics and Metabolism in Children and Adolescents

Principal investigator · Completed

Children's Hospital Los Angeles

Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software

Principal investigator · Completed

Children's Hospital Los Angeles